Neurocrine Biosciences, Inc.
US ˙ NasdaqGS ˙ US64125C1099

SecurityNBIX / Neurocrine Biosciences, Inc.
InstitutionNeuberger Berman Group LLC
Latest Disclosed Ownership11,535 shares
Latest Disclosed Value $ 1,519,621
Neuberger Berman Group LLC reports 3.37% increase in ownership of NBIX / Neurocrine Biosciences, Inc.

On May 14, 2026 - Neuberger Berman Group LLC filed a 13F-HR form disclosing ownership of 11,535 shares of Neurocrine Biosciences, Inc. (US:NBIX) valued at $1,519,621 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 11,159 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 3.37% during the quarter. The current value of the position is $1,904,544 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F NEUROCRINE BIOSCIENCES Common 64125C109 11,535 376 3.37 1,520 -3.98 0.0012
2026-02-13 2025-12-31 13F NEUROCRINE BIOSCIENCES Common 64125C109 11,159 606 5.74 1,583 6.82 0.0012
2025-11-12 2025-09-30 13F NEUROCRINE BIOSCIENCES Common 64125C109 10,553 -12 -0.11 1,481 11.61 0.0011
2025-08-25 2025-06-30 13F/A-1 NEUROCRINE BIOSCIENCES Common 64125C109 10,565 1,857 21.33 1,328 37.80 0.0010
2025-08-13 2025-06-30 13F NEUROCRINE BIOSCIENCES Common 64125C109 10,565 1,857 1,328 0.0005
2025-05-13 2025-03-31 13F NEUROCRINE BIOSCIENCES Common 64125C109 8,708 -159,468 -94.82 963 -95.81 0.0008
2025-02-13 2024-12-31 13F NEUROCRINE BIOSCIENCES Common 64125C109 168,176 8,633 5.41 22,956 24.88 0.0182
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES Common 64125C109 159,543 35,802 28.93 18,383 7.91 0.0143
2024-11-14 2024-06-30 13F/A-1 NEUROCRINE BIOSCIENCES Common 64125C109 123,741 6,709 5.73 17,035 5.54 0.0140
2024-08-13 2024-06-30 13F NEUROCRINE BIOSCIENCES Common 64125C109 123,741 6,709 17,035 0.0140
2024-11-14 2024-03-31 13F/A-1 NEUROCRINE BIOSCIENCES Common 64125C109 117,032 3,275 2.88 16,141 7.69 0.0133
2024-05-13 2024-03-31 13F NEUROCRINE BIOSCIENCES Common 64125C109 117,032 3,275 16,141 0.0133
2024-11-14 2023-12-31 13F/A-2 NEUROCRINE BIOSCIENCES Common 64125C109 113,757 3,012 2.72 14,989 20.31 0.0131
2024-02-09 2023-12-31 13F NEUROCRINE BIOSCIENCES Common 64125C109 113,757 3,012 14,989 0.0131
2023-11-14 2023-09-30 13F NEUROCRINE BIOSCIENCES Common 64125C109 110,745 355 0.32 12,459 19.68 0.0114
2023-08-11 2023-06-30 13F NEUROCRINE BIOSCIENCES Common 64125C109 110,390 103,961 1,617.06 10,410 1,501.38 0.0093
2023-05-12 2023-03-31 13F NEUROCRINE BIOSCIENCES Common 64125C109 6,429 -33 -0.51 651 -15.69 0.0006
2023-02-13 2022-12-31 13F NEUROCRINE BIOSCIENCES Common 64125C109 6,462 -86 -1.31 772 10.78 0.0008
2022-11-15 2022-09-30 13F NEUROCRINE BIOSCIENCES Common 64125C109 6,548 -1,141 -14.84 696 -7.20 0.0007
2022-08-15 2022-06-30 13F NEUROCRINE BIOSCIENCES Common 64125C109 7,689 207 2.77 750 6.84 0.0008
2022-05-23 2022-03-31 13F/A-1 NEUROCRINE BIOSCIENCES Common 64125C109 7,482 2,948 65.02 702 85.22 0.0006
2022-05-13 2022-03-31 13F NEUROCRINE BIOSCIENCES Common 64125C109 7,482 2,948 699 0.0006
2022-02-11 2021-12-31 13F NEUROCRINE BIOSCIENCES Common 64125C109 4,534 1,365 43.07 379 25.91 0.0003
2021-11-12 2021-09-30 13F NEUROCRINE BIOSCIENCES Common 64125C109 3,169 28 0.89 301 -1.31 0.0003
2021-08-13 2021-06-30 13F NEUROCRINE BIOSCIENCES Common 64125C109 3,141 191 6.47 305 6.27 0.0003
2021-05-13 2021-03-31 13F NEUROCRINE BIOSCIENCES Common 64125C109 2,950 -330 -10.06 287 -8.89 0.0003
2021-02-10 2020-12-31 13F NEUROCRINE BIOSCIENCES Common 64125C109 3,280 19 0.58 315 0.32 0.0003
2020-11-12 2020-09-30 13F NEUROCRINE BIOSCIENCES Common 64125C109 3,261 330 11.26 314 -12.29 0.0004
2020-08-13 2020-06-30 13F NEUROCRINE BIOSCIENCES Common 64125C109 2,931 -51,832 -94.65 358 -92.45 0.0004
2020-05-14 2020-03-31 13F NEUROCRINE BIOSCIENCES Common 64125C109 54,763 -5,827 -9.62 4,740 -27.22 0.0072
2020-02-12 2019-12-31 13F NEUROCRINE BIOSCIENCES Common 64125C109 60,590 -2,135 -3.40 6,513 15.23 0.0076
2019-11-13 2019-09-30 13F NEUROCRINE BIOSCIENCES Common 64125C109 62,725 62,725 5,652 0.0069
2019-08-13 2019-06-30 13F NEUROCRINE BIOSCIENCES Common 64125C109 0 -80,284 -100.00 0 -100.00
2019-05-13 2019-03-31 13F NEUROCRINE BIOSCIENCES Common 64125C109 80,284 -77,663 -49.17 7,073 -37.29 0.0087
2019-02-12 2018-12-31 13F NEUROCRINE BIOSCIENCES Common 64125C109 157,947 -126,635 -44.50 11,279 -67.77 0.0157
2018-11-16 2018-09-30 13F/A-1 NEUROCRINE BIOSCIENCES Common 64125C109 284,582 -46,913 -14.15 34,990 7.44 0.0396
2018-11-13 2018-09-30 13F NEUROCRINE BIOSCIENCES Common 64125C109 284,582 -46,913 34,990
2018-08-13 2018-06-30 13F NEUROCRINE BIOSCIENCES Common 64125C109 331,495 -29,300 -8.12 32,566 8.84 0.0360
2018-05-08 2018-03-31 13F NEUROCRINE BIOSCIENCES Common 64125C109 360,795 -116,000 -24.33 29,921 -19.12 0.0342
2018-02-14 2017-12-31 13F NEUROCRINE BIOSCIENCES Common 64125C109 476,795 21,500 4.72 36,995 32.60 0.0425
2017-11-15 2017-09-30 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 455,295 -9,309 -2.00 27,900 30.54 0.0349
2017-08-08 2017-06-30 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 464,604 33,021 7.65 21,372 14.36 0.0274
2017-05-10 2017-03-31 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 431,583 112,500 35.26 18,688 51.33 0.0241
2017-02-06 2016-12-31 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 319,083 302,704 1,848.12 12,349 1,389.63 0.0166
2016-11-02 2016-09-30 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 16,379 16,379 0.00 829 0.0011
2016-08-05 2016-06-30 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 0 -10,352 -100.00 0 -100.00
2016-05-06 2016-03-31 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 10,352 -16,135 -60.92 409 -72.70 0.0006
2016-01-28 2015-12-31 13F NEUROCRINE BIOSCIENCES COMMON STOCK 64125C109 26,487 26,487 1,498 0.0020
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.